Effect of silymarin on biliary bile salt secretion in the rat

被引:25
作者
Crocenzi, FA [1 ]
Pellegrino, JM [1 ]
Pozzi, EJS [1 ]
Mottino, AD [1 ]
Garay, EAR [1 ]
Roma, MG [1 ]
机构
[1] Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt, RA-2000 Rosario, Santa Fe, Argentina
关键词
silymarin; hepatoprotection; bile secretion; bile salt output; ursodeoxycholate; muricholate;
D O I
10.1016/S0006-2952(99)00407-4
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The effect of the hepatoprotector silymarin on bile secretion, with particular regard to bile salt secretion, was studied in Wistar rats. Silymarin (25, 50, 100, and 150 mg/kg/day, i.p., for 5 days) induced a dose-dependent increase in bile flow and bile salt secretion, the maximal effect being reached at a dose of 100 mg/kg/day (+17 and +49%, for bile flow and bile salt output, respectively; P < 0.05). Assessment of bile salt composition in bile revealed that stimulation of the bile salt secretion was accounted for mainly by an increase in the biliary secretion of beta-muricholate and, to a lesser extent, of alpha-muricholate, chenodeoxycholate, ursodeoxycholate, and deoxycholate. The maximum secretory rate (T-m) of bile salts, as assessed by infusing the non-hepatotoxic bile salt tauroursodeoxycholate i.v. at stepwise-increasing rates, was not influenced by silymarin. The flavonolignan also increased the endogenous bile salt pool size (+53%, P < 0.05) and biliary bile acid excretion after bile acid pool depletion (+54%, P < 0.05), a measure of de novo bile salt synthesis. These results suggest that silymarin increases the biliary excretion and the endogenous pool of bile salts by stimulating the synthesis, among others, of hepatoprotective bile salts, such as beta-muricholate and ursodeoxycholate. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1015 / 1022
页数:8
相关论文
共 44 条
[1]
ADAPTIVE REGULATION OF HEPATIC BILE-SALT TRANSPORT - EFFECT OF PROLONGED BILE-SALT DEPLETION IN THE RAT [J].
ACCATINO, L ;
HONO, J ;
MALDONADO, M ;
ICARTE, MA ;
PERSICO, R .
JOURNAL OF HEPATOLOGY, 1988, 7 (02) :215-223
[2]
INHIBITORY ACTION OF SILYMARIN OF LIPID PEROXIDE FORMATION IN RAT-LIVER MITOCHONDRIA AND MICROSOMES [J].
BINDOLI, A ;
CAVALLINI, L ;
SILIPRANDI, N .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (24) :2405-2409
[3]
Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats [J].
Boigk, G ;
Stroedter, L ;
Herbst, H ;
Waldschmidt, J ;
Riecken, EO ;
Schuppan, D .
HEPATOLOGY, 1997, 26 (03) :643-649
[4]
BORUM M, 1990, GASTROENTEROLOGY, V100, P283
[5]
Carey Martin C., 1994, P719
[6]
STUDIES ON THE ANTIOXIDANT AND FREE-RADICAL SCAVENGING PROPERTIES OF IDB-1016 A NEW FLAVANOLIGNAN COMPLEX [J].
COMOGLIO, A ;
LEONARDUZZI, G ;
CARINI, R ;
BUSOLIN, D ;
BASAGA, H ;
ALBANO, E ;
TOMASI, A ;
POLI, G ;
MORAZZONI, P ;
MAGISTRETTI, MJ .
FREE RADICAL RESEARCH COMMUNICATIONS, 1990, 11 (1-3) :109-115
[7]
CZYGAN P, 1972, BILE ACIDS HUMAN DIS, P135
[8]
DAVIS RA, 1976, GASTROENTEROLOGY, V70, P1130
[9]
Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin [J].
Dehmlow, C ;
Erhard, J ;
deGroot, H .
HEPATOLOGY, 1996, 23 (04) :749-754
[10]
MODIFICATIONS OF LIVER BILE-ACIDS POOL DURING MODULATION OF RAT HEPATOCARCINOGENESIS BY PHENOBARBITAL AND NAFENOPIN [J].
DELZENNE, NM ;
TAPER, HS ;
ROBERFROID, M .
ARCHIVES OF TOXICOLOGY, 1994, 68 (06) :394-397